<DOC>
	<DOCNO>NCT02032485</DOCNO>
	<brief_summary>The purpose study determine Near-Infrared fluorescence image effective approach detect colorectal tumoral tissue peritoneal implant colorectal cancer patient .</brief_summary>
	<brief_title>Near-Infrared Imaging Peritoneal Carcinomatosis From Colorectal Cancer</brief_title>
	<detailed_description>Primary objective Evaluation ability NIR image use ICG demonstrate ( gross tumoral mass and/or ) peritoneal metastatic `` implant `` patient operated peritoneal carcinomatosis colorectal carcinoma Secondary objective : Definition histological distribution ( vessel , extravascular space , specific cell ) IV inject ICG normal pathological tissue ( , demonstrate per-operatively , ) node patient find fluorescent remove and/or b ) level fluorescent focus observe level hepatic surface ) Methodology : The day operation : ICG 0.125 mg/kg give iv injection day operation . In operating room : When patient operate , surgeon ( `` conventional '' video control ) search establish usual presence ( `` gross '' tumoral mass ) metastatic deposit level peritoneal surface . NIR image acquire manoeuvers , detect , fluorescent structure and/or foci anatomically defined surgeon . If ( `` gross '' tumoral mass and/or ) metastatic deposit see fluorescent , operation continue usual anatomical piece control `` ex vivo '' fluorescent character . All fluorescent foci anatomical piece identify mark and/or `` suture '' . If ( `` gross '' tumoral mass and/or ) metastatic deposit see fluorescent , ICG 0.125 mg/kg give iv injection vascularization , income ICG tumoral implant ( judge surgeon representative patient 's status ) dynamically study use PDE camera 10 minute follow IV injection . If hepatic metastasis pre-operatively document , surface liver control , superficial fluorescent focus observe , biopsied . In Laboratory Pathology : The tumoral tissue well -if identified- `` non identified tumoral '' fluorescent tissular focus process usual . All slide obtain analyzed use near-infrared fluorescence microscope presence absence ( detectable ) ICG different ICG-positive compartment ( vascular space , interstitial space , normal and/or tumoral cell , macrophage , â€¦ ) determine .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<criteria>Patients ( either newly diagnose , relapse ) peritoneal carcinomatosis histopathologically proven colorectal carcinoma candidate `` open '' surgery , Informed consent form sign . Age less than18 year old . Inability give inform consent . History allergy hypersensitivity investigational product ( active substance ingredient ) , iodine shellfish . Apparent hyperthyroidism , autonomous thyroid adenoma , unifocal , multifocal disseminate autonomy thyroid gland . Documented coronary disease . Advanced renal impairment ( creatinine &gt; 1,5mg/dl ) . During 2 week enrolment , concurrent medication reduces increase extinction ICG ( i.e . anticonvulsant , haloperidol Heparin ) . Pregnancy , breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>colorectal cancer</keyword>
	<keyword>Indocyanine Green</keyword>
	<keyword>visualization peritoneal metastasis</keyword>
</DOC>